Work

A Phase I Trial of Immunocytokine HU14.18-IL2 in Children with Recurrent or Refractory Neuroblastoma and Other GD2 Positive Malignancies: A Study of the Children's Oncology Group

Year: 2004

Type: article

Source: Journal of Immunotherapy

DOI: 10.1097/00002371-200411000-00198

Authors: K Osenga, J Hank, M Albertini, J Gan, A Sternberg, R Seeger, K Matthay, P Reynolds, M Krailo, P Adamson, R Reisfeld, S Gillies, P Sondel

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Children's Hospital Los Angeles, University of California, San Francisco, Arcadia, Children's Hospital of Philadelphia, Scripps Research Institute

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2088959324

FWCI: 0.211

Cites:

Cited by: 3

Related to: 10